FOLFIRINOX vs gemcitabine nab-paclitaxel: A real-world efficacy and safety analysis - a single-centre experience

被引：0
|
作者：
Khan, A. M. [1 ]
Noor, S. [2 ]
Ahmed, R. [3 ]
Takreem, S. [2 ]
Shahnoor, S. S. [2 ]
Muddu, V. K. [2 ,4 ]
Bonda, A. [5 ]
Siripurapu, I. [5 ]
Krishnaiah, S. [6 ]
Rao, G. [7 ]
Reddy, N. [8 ]
机构：
[1] Asian Inst Gastroenterol, Dept Med Oncol, Hyderabad, India
[2] Anwarul Uloom Coll Pharm, Pharm Practice, Hyderabad, India
[3] Anwarul Uloom Coll Pharm, Pharm, Hyderabad, India
[4] AIG Hosp Hyderabad, Med Oncol, Hyderabad, India
[5] AIG Hosp, Dept Med Oncol, Hyderabad, India
[6] Asian Inst Gastroenterol, Biostat, Hyderabad, India
[7] Asian Inst Gastroenterol, Surg Gastroenterol, Hyderabad, India
[8] Asian Inst Gastroenterol, Med Gastroenterol, Hyderabad, India
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.517
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
376P
引用
收藏
页码：S152 / S152
页数：1
相关论文
共 50 条
  • [1] Real-world experience with FOLFIRINOX and gemcitabine plus nab-paclitaxel in the treatment of pancreatic cancer in Japan
    Maeda, O.
    Yokoyama, Y.
    Yamaguchi, J.
    Ota, A.
    Matsuoka, A.
    Morita, S.
    Inoue, M.
    Mizutani, T.
    Shimokata, T.
    Urakawa, H.
    Mitsuma, A.
    Nagino, M.
    Ando, Y.
    ANNALS OF ONCOLOGY, 2017, 28 : 69 - 69
  • [2] A Real-World Comparison of FOLFIRINOX, Gemcitabine Plus nab-Paclitaxel, and Gemcitabine in Advanced Pancreatic Cancers
    Wang, Ying
    Camateros, Pierre
    Cheung, Winson Y.
    JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (01) : 62 - 68
  • [3] A Real-World Comparison of FOLFIRINOX, Gemcitabine Plus nab-Paclitaxel, and Gemcitabine in Advanced Pancreatic Cancers
    Ying Wang
    Pierre Camateros
    Winson Y. Cheung
    Journal of Gastrointestinal Cancer, 2019, 50 : 62 - 68
  • [4] Clinical outcomes of FOLFIRINOX and gemcitabine/nab-paclitaxel in the real world setting
    Franco, Fernando Franco
    Juan, Camara C.
    Valades, Jose Ignacio Martin
    Marrupe, David
    Abad, David Gutierrez
    Leon, Ana
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [5] Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study
    Sonia Zaibet
    Vincent Hautefeuille
    Edouard Auclin
    Astrid Lièvre
    David Tougeron
    Mathieu Sarabi
    Marine Gilabert
    Julie Wasselin
    Julien Edeline
    Pascal Artru
    Dominique Bechade
    Clémence Morin
    Agnes Ducoulombier
    Julien Taieb
    Simon Pernot
    British Journal of Cancer, 2022, 126 : 1394 - 1400
  • [6] Real-world outcomes of FOLFIRINOX vs gemcitabine and nab-paclitaxel in advanced pancreatic cancer: A population-based propensity score-weighted analysis
    Chan, Kelvin K. W.
    Guo, Helen
    Cheng, Sierra
    Beca, Jaclyn M.
    Redmond-Misner, Ruby
    Isaranuwatchai, Wanrudee
    Qiao, Lucy
    Earle, Craig
    Berry, Scott R.
    Biagi, James J.
    Welch, Stephen
    Meyers, Brandon M.
    Mittmann, Nicole
    Coburn, Natalie
    Arias, Jessica
    Schwartz, Deborah
    Dai, Wei F.
    Gavura, Scott
    McLeod, Robin
    Kennedy, Erin D.
    CANCER MEDICINE, 2020, 9 (01): : 160 - 169
  • [7] Real-world efficacy and safety of ritlecitinib in alopecia areata: A single-centre experience
    Sheng, Youyu
    Wang, Qin
    Tao, Ke
    Yang, Kai
    Zhu, Yifei
    Li, Zheng
    Ni, Chunya
    Lin, Jinran
    Wu, Wenyu
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025,
  • [8] Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review
    Chiorean, Elena Gabriela
    Cheung, Winston Y.
    Giordano, Guido
    Kim, George
    Al-Batran, Salah-Eddin
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [9] Real-World Cost-Effectiveness of First-Line Gemcitabine Plus Nab-Paclitaxel vs FOLFIRINOX in Patients With Advanced Pancreatic Cancer
    Arciero, Vanessa
    Luo, Jin
    Parmar, Ambica
    Dai, Wei Fang
    Beca, Jaclyn M.
    Raphael, Michael J.
    Isaranuwatchai, Wanrudee
    Habbous, Steven
    Tadrous, Mina
    Earle, Craig C.
    Biagi, Jim J.
    Mittmann, Nicole
    Arias, Jessica
    Gavura, Scott
    Chan, Kelvin K. W.
    JNCI CANCER SPECTRUM, 2022, 6 (04)
  • [10] Gemcitabine plus Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study
    Zaibet, Simon
    Hautefeuille, Vincent
    Auclin, Edouard
    Lievre, Astrid
    Tougeron, David
    Sarabi, Mathieu
    Gilabert, Marine
    Wasselin, Julie
    Edeline, Julien
    Artru, Pascal
    Bechade, Dominique
    Morin, Clemence
    Ducoulombier, Agnes
    Taieb, Julien
    Pernot, Simon
    BRITISH JOURNAL OF CANCER, 2022, 126 (10) : 1394 - 1400
12345